Rasph

Axiles Bionics and the EIC Accelerator: The Powered Foot Waits

September 30, 2026882 words5 min

Axiles Bionics, a 2019 spin-off from the BruBotics robotics group at the Vrije Universiteit Brussel, makes prosthetic feet that imitate the human ankle. Founder and CEO Pierre Cherelle began the research as a doctoral student. Its EIC project, Solaris, set out to build "next-generation bionic prostheses combining advanced robotics & AI", sold under a "Prosthetics-as-a-Service" model with monitoring, predictive maintenance and upgrades, according to CORDIS.

The European Innovation Council granted €2,500,000 towards a €3.80 million project from July 2023 to February 2026. The only published report says development was "progressing towards a commercial product: AI-powered active-power electromechanical device". In June 2025 Axiles closed the first €6 million of an €8 million Series A led by PE Group, with the EIC Fund and Finance&Invest.brussels, to sell its existing Lunaris foot and advance the next device, "currently in advanced development". Its website lists only Lunaris products.

€2.50MEIC grant, 66% of a €3.80M project
€6MSeries A first tranche with the EIC Fund, 2025
€-1.07MResult, 2025
Not launchedPowered Solaris foot

Company file

Legal entity
Axiles Bionics, BE0719695854, Brussels
Founded
January 2019
Founders
Pierre Cherelle (CEO), Felipe Gomez (CTO), Claire Cherelle (CRO), Jacques Langhendries (CFO)
Products
Lunaris Essential, Lunaris IO and IO+ (CE-marked, FDA-cleared)
Investors
PE Group, EIC Fund, Finance&Invest.brussels
Staff
12 on average (2025)
EIC project
Solaris, 1 Jul 2023 to 28 Feb 2026, closed

Where Axiles Bionics Stands Now

Lunaris went on sale in January 2023 in Belgium, France, Luxembourg and the Netherlands, according to the company's launch announcement. By 2025 Axiles said it was "CE-marked, FDA-cleared, and reimbursed across multiple countries" and that "clinical adoption is rising sharply". The powered device funded by the EIC has not been launched. Its articles of association were amended twice in 2025, Belgian register publications show.

"Axiles Bionics exemplifies the kind of science-driven innovation Europe needs to stay globally competitive in health technology and human-centric robotics."

Svetoslava Georgieva, Chair, EIC Fund Board, June 2025

The Technology: An Artificial Achilles Tendon

Lunaris uses an elastic tendon connected to an anatomical ankle joint that stores and releases energy while walking. Solaris goes further: an AI-controlled motor drives the ankle up and down, adding push-off power. Cherelle has explained that a single motor strong enough would be too bulky, so the design combines a motor with springs and a freewheel mechanism. The application said more than 85% of test subjects called the design "a must-have".

What the EIC Project Promised, and What CORDIS Shows

The project was to bring Solaris to market with a service model. The first-period report, updated in September 2024, shows development under way. No final report has been published, and the June 2025 funding release still described the device as in advanced development. CORDIS lists the project as closed.

  1. Powered foot developmentIn progressAdvanced development, 2025.
  2. Market launch of SolarisNot yetNot on product list.
  3. Follow-on fundingDelivered€6M with EIC Fund.
  4. Final reportingPendingNot on CORDIS.

The Money

Axiles's filings show a gross margin that rose from €100,468 in 2022 to €469,418 in 2024, then fell to €19,216 in 2025, while the loss doubled to €1.07 million, according to Companyweb. Equity reached €8.30 million after the Series A tranche. Belgian small-company accounts do not show revenue, so Lunaris sales are not public.

What Cannot Be Checked

Questions for the EIC

How much the EIC Fund invested, when Solaris will launch, whether the last €2 million of the Series A closed and why gross margin fell in 2025 are not public.

Why Europe Should Care

In 2019 Cherelle told Le Soir that only about ten research groups worldwide were working on powered ankles, and Axiles argues that prosthetic feet "had barely evolved". The EIC backed a European device with both grant and equity. Its value to amputees depends on the powered foot reaching them.

What the project promised

An AI-powered bionic foot sold as a service with monitoring and upgrades.

What the record shows

A device still in development, a passive foot on sale, a €6 million raise and a doubled loss.

The Verdict

Funded, not yet delivered

Axiles has a real product and fresh investors, including the EIC Fund. The powered foot the EIC grant paid to develop had not reached the market when the project closed.

Axiles Bionics and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.

Start with the EIC Accelerator

Professional proposal writing and expert review for Step 1 and Step 2.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#Axiles Bionics#prosthetics#bionics#robotics#medical devices#Belgium
Loading